Livento Group, Inc. (NUGN)
OTCMKTS · Delayed Price · Currency is USD
0.0013
-0.0001 (-7.69%)
Aug 1, 2025, 3:56 PM EDT
Revance Therapeutics Market Cap
Livento Group has a market cap or net worth of $1.61 million as of August 1, 2025. Its market cap has decreased by -83.79% in one year.
Market Cap
1.61M
Enterprise Value
1.64M
Revenue
1.70M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since February 4, 2015, Livento Group's market cap has decreased from 2.41M to 1.61M, a decrease of -33.04%. That is a compound annual growth rate of -3.75%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 31, 2025 | 1.74M | -38.53% |
Dec 31, 2024 | 2.82M | -70.81% |
Dec 29, 2023 | 9.67M | -30.83% |
Dec 30, 2022 | 13.98M | -26.98% |
Dec 31, 2021 | 19.15M | 5,376.94% |
Dec 31, 2020 | 349.60K | 542.13% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Jingbo Technology | 2.84B |
IPE Universal | 1.56B |
AI Unlimited Group | 711.70M |
Rand Worldwide | 487.11M |
Applied Energetics | 468.44M |
EACO Corporation | 316.00M |
Motomova | 308.56M |
Abaxx Technologies | 305.85M |